• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vasoactive intestinal peptide hydrolysis by antibody light chains.

作者信息

Mei S, Mody B, Eklund S H, Paul S

机构信息

Department of Pharmacology, University of Nebraska Medical Center, Omaha 68198-6260.

出版信息

J Biol Chem. 1991 Aug 25;266(24):15571-4.

PMID:1908455
Abstract

This paper describes evidence for hydrolysis of a neuropeptide, vasoactive intestinal peptide (VIP), by light chains purified from the IgG of a human subject positive for VIP binding antibodies. Purified IgG was digested with papain, resultant fragment antigen binding (Fab) fragments were reduced with 2-mercaptoethanol and alkylated with iodoacetamide, and light chains were purified by chromatography on immobilized antibodies to light chains and immobilized antibodies to heavy chains. Non-immunoglobulin components were undetectable in the light chain preparation, judged by sodium dodecyl sulfate-electrophoresis and Western blotting with anti-heavy and anti-light chain antibodies. The light chains hydrolyzed VIP with specific activity 32-fold greater than that of Fab, the pH optimum for light chain-mediated VIP hydrolysis was 7.0-7.5, and the hydrolytic activity was saturable (Vmax, 0.19 pmol/min/microgram light chains; substrate concentration at Vmax/2,380 nM).

摘要

相似文献

1
Vasoactive intestinal peptide hydrolysis by antibody light chains.
J Biol Chem. 1991 Aug 25;266(24):15571-4.
2
Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody.人自身抗体对血管活性肠肽的催化水解作用。
Science. 1989 Jun 9;244(4909):1158-62. doi: 10.1126/science.2727702.
3
Low level formation of potent catalytic IgG fragments mediated by disulfide bond instability.由二硫键不稳定性介导的强效催化性IgG片段的低水平形成。
Mol Immunol. 1996 May-Jun;33(7-8):593-600. doi: 10.1016/0161-5890(96)00021-1.
4
Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies.
J Biol Chem. 1991 Aug 25;266(24):16128-34.
5
Molecular cloning of a proteolytic antibody light chain.一种蛋白水解抗体轻链的分子克隆
J Biol Chem. 1994 Dec 23;269(51):32389-93.
6
Binding and multiple hydrolytic sites in epitopes recognized by catalytic anti-peptide antibodies.催化性抗肽抗体识别的表位中的结合位点和多个水解位点。
Ciba Found Symp. 1991;159:156-67; discussion 167-73. doi: 10.1002/9780470514108.ch11.
7
Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display.通过噬菌体展示筛选出的高效水解血管活性肠肽的自身抗体轻链
Biochim Biophys Acta. 1996 Aug 23;1316(3):217-23. doi: 10.1016/0925-4439(96)00028-2.
8
Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.蛋白水解性抗体轻链的切割特异性及重链可变区的作用
J Mol Biol. 1997 Aug 22;271(3):374-85. doi: 10.1006/jmbi.1997.1196.
9
Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide.
J Immunol. 1990 Aug 15;145(4):1196-9.
10
Antigen recognition by an antibody light chain.抗体轻链对抗原的识别。
J Biol Chem. 1994 Jan 7;269(1):734-8.

引用本文的文献

1
Structural and biochemical differences between non-catalytic and catalytic antibodies.非催化抗体与催化抗体之间的结构和生化差异。
MAbs. 2025 Dec;17(1):2503978. doi: 10.1080/19420862.2025.2503978. Epub 2025 May 12.
2
Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies.将鼠单克隆抗体酶解为相应的催化抗体。
Sci Rep. 2024 May 28;14(1):12184. doi: 10.1038/s41598-024-63116-6.
3
Some structural features of the peptide profile of myelin basic protein-hydrolyzing antibodies in schizophrenic patients.
精神分裂症患者髓鞘碱性蛋白水解抗体的肽谱的一些结构特征。
PeerJ. 2023 Jul 6;11:e15584. doi: 10.7717/peerj.15584. eCollection 2023.
4
Direct conversion of a general antibody to its catalytic antibody and corresponding applications -Importance and role of Pro95 in CDR-3.将通用抗体直接转化为其催化抗体及相应应用——Pro95 在 CDR-3 中的重要性和作用。
Proc Jpn Acad Ser B Phys Biol Sci. 2023;99(6):155-172. doi: 10.2183/pjab.99.010.
5
Obtaining Highly Active Catalytic Antibodies Capable of Enzymatically Cleaving Antigens.获得能够酶切抗原的高活性催化抗体。
Int J Mol Sci. 2022 Nov 18;23(22):14351. doi: 10.3390/ijms232214351.
6
A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain.H34 催化抗体轻链中具有新的催化部位,可发挥抗原切割作用。
Sci Rep. 2022 Nov 10;12(1):19185. doi: 10.1038/s41598-022-23689-6.
7
Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans.催化活性抗体(Abzymes)在动物和人类中具有氧化还原抗氧化功能,是必不可少的保护作用。
Int J Mol Sci. 2022 Mar 31;23(7):3898. doi: 10.3390/ijms23073898.
8
Finding and characterizing a catalytic antibody light chain, H34, capable of degrading the PD-1 molecule.寻找并鉴定一种能够降解PD-1分子的催化抗体轻链H34。
RSC Chem Biol. 2020 Dec 10;2(1):220-229. doi: 10.1039/d0cb00155d. eCollection 2021 Feb 1.
9
A new algorithm to convert a normal antibody into the corresponding catalytic antibody.一种将普通抗体转化为相应催化抗体的新算法。
Sci Adv. 2020 Mar 25;6(13):eaay6441. doi: 10.1126/sciadv.aay6441. eCollection 2020 Mar.
10
New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β-amyloid molecule along with the peptidase activity.将催化功能引入抗体的新技术:一种独特的人类催化抗体轻链,具有β-淀粉样分子降解及肽酶活性。
FASEB Bioadv. 2019 Jan 29;1(2):93-104. doi: 10.1096/fba.1025. eCollection 2019 Feb.